„Pirfenidon“

Suchergebnisse

1.000+ Treffer

• Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
  Zhou, Chaoming ; Liu, Fang ; Gallo, Phillip H. ; Baratz, Mark E. ; Kathju, Sandeep ; Satish, Latha
• Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
  Costabel, Ulrich ; Bendstrup, Elisabeth ; Cottin, Vincent ; Dewint, Pieter ; Egan, Jim J. J. ; Ferguson, James ; Groves, Richard ; Hellström, Per M. ; Kreuter, Michael ; Maher, Toby M. ; Molina-Molina, Maria ; Nordlind, Klas ; Sarafidis, Alexandre ; Vancheri, Carlo
• Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C
  Flores-Contreras, Lucia ; Sandoval-Rodríguez, Ana S. ; Mena-Enriquez, Mayra G. ; Lucano-Landeros, Silvia ; Arellano-Olivera, Inmaculada ; Álvarez-Álvarez, Arnulfo ; Sanchez-Parada, M Guadalupe ; Armendariz-Borunda, Juan
• Einsatz antifibrotischer Medikamente bei interstitiellen Lungenerkrankungen
  Kreutz, Claus-Peter ; Gesierich, Wolfgang ; Behr, Jürgen ; Kneidinger, Nikolaus
• Engineering Macrophage‐Derived Exosome to Deliver Pirfenidone: A Novel Approach to Combat Silicotic Pulmonary Fibrosis (Adv. Healthcare Mater. 4/2025)
  Chen, Zhen ; Yun, Xiang ; Tian, Jiaqi ; Li, Fei ; Zhang, Zitong ; Meng, Jiahua ; Li, Ning ; Bian, Hongying ; Duan, Shuyin ; Zhang, Lin
• Nintedanib more cost effective than pirfenidone for IPF?
• The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
  Mediavilla-Varela, Melanie ; Boateng, Kingsley ; Noyes, David ; Antonia, Scott J.
• Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
  Kreuter, Michael ; Maher, Toby M. ; Corte, Tamera J. ; Molina-Molina, Maria ; Axmann, Judit ; Gilberg, Frank ; Kirchgaessler, Klaus-Uwe ; Cottin, Vincent
• Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study
  Miedema, Jelle R. ; Moor, Catharina ; Veltkamp, Marcel ; Baart, Sara ; Lie, Natascha S. L. ; Grutters, Jan C. ; Wijsenbeek, Marlies S. ; Mostard, Rémy L. M.
• Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
  Costabel, Ulrich ; Albera, Carlo ; Glassberg, Marilyn K. ; Lancaster, Lisa H. ; Wuyts, Wim A. ; Petzinger, Ute ; Gilberg, Frank ; Kirchgaessler, Klaus-Uwe ; Noble, Paul W.
• Reply-Letter to the Editor: Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use
  Lyseng-Williamson, Katherine A.
• Comment on: ‘Pirfenidone Tablets in Idiopathic Pulmonary Fibrosis: A Profile of Their Use’
  Stowasser, Susanne ; Quaresma, Manuel ; Rieck, Markus
• Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies
  Behr, Jürgen ; Nathan, Steven D. ; Costabel, Ulrich ; Albera, Carlo ; Wuyts, Wim A. ; Glassberg, Marilyn K. ; Haller, Harold ; Alvaro, Giuseppe ; Gilberg, Frank ; Samara, Katerina ; Lancaster, Lisa
• Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort
  Cottin, Vincent ; Guéguen, Sonia ; Nunes, Hilario ; Jouneau, Stéphane ; Crestani, Bruno ; Bonniaud, Philippe ; Wemeau, Lidwine ; Israël-Biet, Dominique ; Reynaud-Gaubert, Martine ; Gondouin, Anne ; Cadranel, Jacques ; Marchand-Adam, Sylvain ; Chevereau, Marie ; Dufaure-Garé, Isabelle ; Amselem, Serge ; Clément, Annick
• Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey
  Lancaster, Lisa H. ; Valenzuela, Claudia ; Mason, Wendi ; Neurohr, Claus ; Ripamonti, Elena ; Kirchgaessler, Klaus-Uwe ; Cottin, Vincent
• Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
  Chung, Man Pyo ; Park, Moo Suk ; Oh, In Jae ; Lee, Heung Bum ; Kim, Young Whan ; Park, Jong Sun ; Uh, Soo Taek ; Kim, Yun Seong ; Jegal, Yangjin ; Song, Jin Woo
• A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
  Prasse, Antje ; Ramaswamy, Murali ; Mohan, Shaun ; Pan, Lin ; Kenwright, Andrew ; Neighbors, Margaret ; Belloni, Paula ; LaCamera, Peter P.
• Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
  Glassberg, Marilyn K. ; Nathan, Steven D. ; Lin, Chin-Yu ; Morgenthien, Elizabeth A. ; Stauffer, John L. ; Chou, Willis ; Noble, Paul W.
• The Effectiveness, Safety, and Tolerability of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Retrospective Study
  Hanta, Ismail ; Cilli, Aykut ; Sevinc, Can
• Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
  Wencel, Mark L. ; Haselkorn, Tmirah ; Limb, Susan L. ; Stauffer, John L. ; Morgenthien, Elizabeth ; Raimundo, Karina ; LaCamera, Peter P.